DNA

How oral and dental hygiene plays a role in glaucomaIn the past couple of years, there has been discussion regarding dental and oral health—specifically the oral biomicrome—as possibly having a relationship to glaucoma.
Photoactivation holds promise for keratitis treatment
Photoactivation holds promise for keratitis treatmentThe same photoactivation process used in collagen cross-linking for keratoconus can kill bacteria without the need for the oxygen responsible for the biomechanical effects, potentially pointing toward better treatments for keratitis, according to Olivier Richoz, MD, PhD.
[BLOG]: Clinical pharmacogenomics: Meeting the needs of the community through a dedicated clinic
[BLOG]: Clinical pharmacogenomics: Meeting the needs of the community through a dedicated clinicBLOG: Pharmacogenomics is the study of how DNA differences affect response to medications. This can explain why similar patients have different reactions to the same medication even if they receive the same dosage. The pharmacogenomics clinic at NorthShore is the first step toward a larger implementation.
AMD genetic testing could lead to early diagnosis, better treatmentOptometry Times Editorial Advisory Board members Steven Ferrucci, OD, FAAO, and Diana Shechtman, OD, FAAO, discussed the benefits of genetic tests for age-related macular degeneration (AMD) at the American Optometric Association’s Optometry’s Meeting.
Avellino launches DNA test for LASIK safetyAvellino Lab USA recently launched the Avellino DNA Dual Test for LASIK Safety, a genetic test that can detect both Granular Corneal Dystrophy (GCD) type 1 and Avellino Corneal Dystrophy (also known as GCD2).
Genetic test designed to make LASIK saferAvellino Lab USA announced the availability of its new Avellino DNA dual test for LASIK safety, a genetic test that can detect both Avellino Corneal Dystrophy (ACD) and another genetic mutation, Granular Corneal Dystrophy type 1 (GCD1).
Autism and gender: Are boys 'predisposed,' girls 'protected'?“We know there is gender bias in neurodevelopmental disorders, ranging from autism to intellectual disability,” begins Bradley P. Coe, PhD, senior fellow, Eichler Lab, Department of Genome Sciences at the University of Washington School of Medicine, Seattle, and coauthor of a new study that may help explain the gender chasm.
FDA panel recommends HPV DNA test as first-line cervical cancer screening
FDA panel recommends HPV DNA test as first-line cervical cancer screeningIn a unanimous vote, a Food and Drug Administration (FDA) advisory committee has recommended that the agency give premarket approval to a human papillomavirus (HPV) DNA test as first-line screening for cervical cancer.
How DNA testing screens for corneal dystrophyA new genetic test for Avellino corneal dystrophy identifies carriers of this rare autosomal dominant mutation. Its presence can lead to visual deterioration and ultimate blindness following corneal refractive surgeries.
Noninvasive fetal diagnosis
Noninvasive fetal diagnosisInstead of invasive procedures such as chorionic villus sampling or amniocentesis, definitive, noninvasive testing for fetal chromosomal abnormalities has long been the "holy grail" in obstetrics. It now appears practical to achieve prenatal genetic diagnosis using cell-free fetal dna in maternal blood.